Association of GCK (rs1799884), GCKR (rs780094), and G6PC2 (rs560887) Gene Polymorphisms with Type 2 Diabetes among Malay Ethnics

Abstract

Background Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder, and the underlying causes remain unknown and have not been fully elucidated. Several candidate genes have been associated with T2DM in various populations with conflicting results. The variations found in glucokinase (GCK), glucokinase regulatory protein (GCKR), and glucose-6-phosphatase 2 (G6PC2) genes were not well studied, particularly among Asians.Aims The main objective of this study was to determine the candidate genetic polymorphisms of GCK (rs1799884), GCKR (rs780094), and G6PC2 (rs560887) genes in T2DM among Malay ethnics.Methods In this candidate gene association study, a total of 180 T2DM subjects and 180 control subjects were recruited to determine the genotypes using polymerase chain reaction-restriction fragment length polymorphism and Taqman probe assay methods. Genotype and allele frequencies in case and control samples were compared using the chi-squared test to determine a significant difference.Results The body mass index, fasting blood glucose, hemoglobin A1c, systolic and diastolic blood pressure, and total cholesterol were significantly different (p < 0.05) between T2DM and control subjects. The genotypic and allelic frequencies of GCK (rs1799884), GCKR (rs780094), and G6PC2 (rs560887) gene polymorphisms were significantly different between T2DM and controls (p < 0.05).Conclusion Hence, rs1799884 of GCK gene and rs780094 of GCKR gene and rs560887 of the G6PC2 gene are possible genetic biomarkers in T2DM development among Malay ethnics in Malaysia.

Keywords

GCK gene polymorphism / diabetes / biomarkers / Malay ethnics

References

[1] Sørensen TIA, Metz S, Kilpeläinen TO. Do gene-environment interactions have implications for the precision prevention of type 2 diabetes? Diabetologia 2022;65(11):1804-1813

[2] Zhang L, Yang H, Yang P. The correlation between type 2 diabetes mellitus and cardiovascular disease risk factors in the elderly. Appl Bionics Biomech 2022;2022:4154426

[3] Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008;88(11):1254-1264

[4] Malaysian Ministry of Health. (2008). Third National Health Morbidity Survey 2006. NHMS III Report, Kuala Lumpur, Institute for Public Health, Ministry of Health, Malaysia

[5] Malaysian Ministry of Health. (2015). Third National Health Morbidity Survey 2015. NHMS IV Report, Kuala Lumpur, Institute for Public Health, Ministry of Health, Malaysia

[6] Chan YY, Lim KK, Lim KH, et al. Physical activity and overweight/ obesity among Malaysian adults: findings from the 2015 National Health andmorbidity survey (NHMS). BMCPublicHealth 2017;17(01):733

[7] Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, et al. Prevalence of diabetes in the Malaysian national healthmorbidity survey III 2006. Med J Malaysia 2010;65(03):180-186

[8] Dendup T, Feng X, Clingan S, Astell-Burt T. Environmental risk factors for developing type 2 diabetes mellitus: a systematic review. Int J Environ Res Public Health 2018;15(01):78

[9] Witka BZ, Oktaviani DJ, Marcellino M, Barliana MI, Abdulah R. Type2 diabetes-associated genetic polymorphisms as potential disease predictors. Diabetes Metab Syndr Obes 2019;12:2689-2706

[10] Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud 2012;9(01):6-22

[11] Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 2002;34(03):207-216

[12] Matschinsky FM, Magnuson MA, Zelent D, et al. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 2006;55(01):1-12

[13] März W, Nauck M, Hoffmann MM, et al. G(-30)A polymorphismin the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. Circulation 2004;109(23):2844-2849

[14] Rose CS, Grarup N, Krarup NT, et al. A variant in the G6PC2/ ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads. Diabetologia 2009;52(10):2122-2129

[15] Chang HW, Lin FH, Li PF, et al. Association between a glucokinase regulator genetic variant and metabolic syndrome in Taiwanese adolescents. Genet Test Mol Biomarkers 2016;20(03):137-142

[16] Qi Q, Wu Y, Li H, et al. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia 2009; 52(05):834-843

[17] Wang H, Liu L, Zhao J, et al. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS One 2013;8(06):e67665

[18] Bouatia-Naji N, Rocheleau G, Van Lommel L, et al. A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 2008;320(5879):1085-1088

[19] Yahaya TO, Salisu TF. A review of type 2 diabetes mellitus predisposing genes. Curr Diabetes Rev 2019;16(01):52-61

[20] Permutt MA,Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invest 2005;115(06):1431-1439

[21] Cargill M, Altshuler D, Ireland J, et al. Characterization of singlenucleotide polymorphisms in coding regions of human genes. Nat Genet 1999;22(03):231-238

[22] Udler MS. Type 2 diabetes: multiple genes,multiple diseases. Curr Diab Rep 2019;19(08):55

[23] Han X, Cui H, Chen X, Xie W, Chang Y. Association of the glucokinase gene promoter polymorphism -30G > A (rs1799884) with gestational diabetes mellitus susceptibility: a case-control study andmeta-analysis. Arch Gynecol Obstet 2015; 292(02):291-298

[24] Da Silva MS, Chartrand D, Vohl MC, Barbier O, Rudkowska I. Dairy product consumption interacts with glucokinase (GCK) gene polymorphisms associated with insulin resistance. J Pers Med 2017;7(03):8

[25] Warner JP, Leek JP, Intody S, Markham AF, Bonthron DT. Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization. Mamm Genome 1995;6(08):532-536

[26] Ling Y, Li X, Gu Q, Chen H, Lu D, Gao X. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study. BMC Med Genet 2011;12(01):66

[27] Wang K, Shi M, Yang A, et al. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019). Diabetes Res Clin Pract 2022; 193:110118

[28] Chen WM, Erdos MR, Jackson AU, et al. Variations in the G6PC2/ ABCB11 genomic region are associatedwith fasting glucose levels. J Clin Invest 2008;118(07):2620-2628

[29] O’Brien RM. Moving on from GWAS: functional studies on the G6PC2 gene implicated in the regulation of fasting blood glucose. Curr Diab Rep 2013;13(06):768-777

[30] Dos Santos C, Bougnères P, Fradin D. A single-nucleotide polymorphismin a methylatable Foxa2 binding site of the G6PC2 promoter is associatedwith insulin secretion in vivo and increased promoter activity in vitro. Diabetes 2009;58(02):489-492

RIGHTS & PERMISSIONS

2023 Global Medical Genetics